Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/13/2024 | $8.50 | Overweight | Cantor Fitzgerald |
| 8/17/2022 | $8.00 | Underperform | Credit Suisse |
| 3/1/2022 | $22.00 → $23.00 | Underperform | BofA Securities |
| 3/1/2022 | $22.00 → $18.00 | Underweight | JP Morgan |
| 3/1/2022 | $33.00 → $18.00 | Hold | Craig Hallum |
| 3/1/2022 | $36.00 → $29.00 | Buy | Lake Street |
| 3/1/2022 | $24.00 → $22.00 | Neutral | B. Riley Securities |
| 11/8/2021 | $36.00 | Buy | Lake Street |
4 - 3D SYSTEMS CORP (0000910638) (Issuer)
4 - 3D SYSTEMS CORP (0000910638) (Issuer)
4 - 3D SYSTEMS CORP (0000910638) (Issuer)
NEW YORK, Sept. 6, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 23, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P SmallCap 600 are more representative of the small-cap market space. The companies being removed from
ROCK HILL, S.C., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE:DDD) announced the appointment of Dr. Rebekah Gee to the 3D Systems Medical Advisory Board, effective March 1, 2023. Dr. Gee is a recognized expert on public health policy and was elected to the National Academy of Medicine in 2017. Dr. Gee will join six other members of the advisory board who have been named since the board's establishment in May 2022: Dr. Stephen K. Klasko, former President and CEO of Thomas Jefferson University and Jefferson Health;The Honorable David J. Shulkin, former U.S. Secretary of Veterans Affairs;The Honorable Alex Azar, former U.S. Health & Human Services Secretary;Dr. Toby Cosgrove, f
ROCK HILL, S.C., Jan. 05, 2023 (GLOBE NEWSWIRE) -- 3D Systems (NYSE:DDD) today announced the appointment of Mr. Bert Bruce to the company's Medical Advisory Board. Mr. Bruce will join the five other members of the advisory board who have been named since the Board's establishment in May 2022: Dr. Stephen K. Klasko, former President and CEO of Thomas Jefferson University and Jefferson Health;The Honorable David J. Shulkin, former U.S. Secretary of Veterans Affairs;The Honorable Alex Azar, former U.S. Health & Human Services Secretary;Dr. Toby Cosgrove, former President & Chief Executive officer of the Cleveland Clinic; andDr. Bon Ku, Professor of Medicine and Design at Thomas Jefferson U
4 - 3D SYSTEMS CORP (0000910638) (Issuer)
4 - 3D SYSTEMS CORP (0000910638) (Issuer)
4 - 3D SYSTEMS CORP (0000910638) (Issuer)
HOUSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Systemic Bio™, a 3D Systems company (NYSE:DDD), is honored to announce its selection as a Top 10 Finalist for the prestigious SLAS 2025 Innovation Award. This recognition underscores the groundbreaking potential of Systemic Bio's proprietary h-VIOS™ platform geared at accelerating drug discovery and development using human-relevant data from bioprinted tissues. The SLAS Innovation Award, presented annually at the SLAS International Conference and Exhibition, celebrates the most innovative technologies poised to impact laboratory science and automation. Systemic Bio was recognized for its cutting-edge platform, which leverages advanced bioprinting
ROCK HILL, S.C., Jan. 06, 2025 (GLOBE NEWSWIRE) -- 3D Systems (NYSE:DDD) announced today that management will participate in the 27th Annual Needham Growth Conference on January 14, 2025. President and CEO, Dr. Jeffrey Graves will participate in a fireside chat at 11:45 a.m. Eastern Standard Time and will participate in individual meetings alongside members of the company's leadership team throughout the day. A live webcast of the conference presentation will be available on 3D Systems' Investor Relations page. The link will be live just prior to the start of the event and will be available for on-demand viewing approximately 24 hours after the event is complete. The webcast recording wi
3D Systems to sell Geomagic® reverse engineering, design, and inspection software portfolio to Hexagon for $123 million, with closure anticipated in first half of 2025Company will sharpen its focus on software solutions that accelerate adoption of 3D printing technologies in large-scale, production application environmentsFocus to be on expansion of capabilities of market-leading platforms, 3D Sprint® and 3DXpert® for polymer and metal printing technologies by leveraging AI and machine learning to deliver improved workflows, higher productivity, reduced costs and improved component quality in production environmentsOqton Industrial Manufacturing OS to focus on critical industrial application
Cantor Fitzgerald initiated coverage of 3D Systems with a rating of Overweight and set a new price target of $8.50
Credit Suisse initiated coverage of 3D Systems with a rating of Underperform and set a new price target of $8.00
BofA Securities reiterated coverage of 3D Systems with a rating of Underperform and set a new price target of $23.00 from $22.00 previously
SC 13G/A - 3D SYSTEMS CORP (0000910638) (Subject)
SC 13G - 3D SYSTEMS CORP (0000910638) (Subject)
SC 13G/A - 3D SYSTEMS CORP (0000910638) (Subject)
8-K - 3D SYSTEMS CORP (0000910638) (Filer)
10-Q - 3D SYSTEMS CORP (0000910638) (Filer)
8-K - 3D SYSTEMS CORP (0000910638) (Filer)
ROCK HILL, S.C., Nov. 26, 2024 (GLOBE NEWSWIRE) -- 3D Systems Corporation (NYSE:DDD) announced today its financial results for the third quarter ended September 30, 2024. Third Quarter Highlights (All numbers are unaudited and are presented in millions, except per share amounts or as otherwise noted) Revenue of $112.9 million decreased 9% year-over-year primarily driven by macro weakness in printer sales, partially offset by approximately 10% growth in consumables salesHealthcare Solutions revenue of $55.1 million grew 5% year-over-year, led by strong growth in Dental and Personalized Healthcare solutionsCustomer interest in 3D printing applications continued to gain mome
ROCK HILL, S.C., Nov. 21, 2024 (GLOBE NEWSWIRE) -- 3D Systems (NYSE:DDD) ("the Company") today announced the Company will release its financial results for third quarter 2024 after the U.S. stock markets close on Tuesday, November 26, 2024. The Company will hold a conference call and simultaneous webcast to discuss these financial results on Wednesday, November 27, 2024 at 8:30 a.m. Eastern Time. Third Quarter 2024 Financial Results Conference CallDate: Wednesday, November 27, 2024Time: 8:30 a.m. Eastern TimeListen via webcast: www.3dsystems.com/investorParticipate via telephone: 201-689-8345The webcast replay will be available approximately two hours after the end of the conference call
Preliminary third quarter 2024 revenue to be approximately $113 million*Q3 materials grew 10% year-over-year and 9% sequentially, offset by declines in printer revenues driven by continued macro-related pressures on capital spending*Record year of product innovation and regulatory approvals supporting future growth in key markets such as Dental, Personalized Healthcare, Aerospace & Defense. This positions the company for exciting future revenue growth as the economy normalizesManagement expects to release and discuss complete third quarter 2024 results the week of November 25, 2024 *The preliminary financial data above and below remains subject to the company's close process. Accordingly, a